Co-Authors
This is a "connection" page, showing publications co-authored by Annalisa Ruggeri and Sara Mastaglio.
Connection Strength
0.276
-
The first case of COVID-19 treated with the complement C3 inhibitor AMY-101. Clin Immunol. 2020 06; 215:108450.
Score: 0.220
-
Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy. Clin Immunol. 2020 11; 220:108598.
Score: 0.056
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.